ONCOLOGIC DRUGS ADVISORY COMMITTEE

ONCOLOGIC DRUGS ADVISORY COMMITTEE

September 16-17, 1999

Slides

First-Line Treatment of Metastatic Colorectal Cancer, Renzo Canetta, MD, Pharmaceutical Research Institute, Bristol-Myers Squibb

Chemotherapy for Metastitic Colorectal Cancer, John S. Macdonald, MD, St. Vincent's Comprehensive Cancer Center

UFT Development, Robert Diasio, MD, University of Alabama

Pivotal Study 011, Steven Benner, MD, Pharmaceutical Research Institute, Bristol-Myers Squibb

Confirmatory Study 012, James Carmichael, MD, PhD, Nottingham City Hospital

Concluding Remarks, Renzo Canetta, MD, Pharmaceutical Research Institute, Bristol-Myers Squibb

The FDA Presentation